Investment Rating - The report maintains a positive outlook on the humanoid robot industry, emphasizing the importance of software development for commercialization [3][4]. Core Insights - The report identifies that the hardware maturity of humanoid robots is currently higher than that of software, with software being the key to commercialization. It highlights the need for advancements in algorithms, data, and control systems to drive the industry forward [3][5][6]. Summary by Sections 1. Algorithms: The Core of Embodied Intelligence - The algorithm framework is divided into two levels: the upper "brain" focuses on task-level planning and decision-making, while the lower "cerebellum" handles real-time motion planning and joint control [3][11][18]. - The report discusses the evolution of control algorithms, noting a shift from traditional methods to modern approaches like reinforcement learning (RL) and imitation learning (IL) [3][19][29]. - The VLA (Vision-Language-Action) model is highlighted as a significant advancement in upper-level control, enabling robots to understand and execute tasks through natural language processing [3][36][40]. 2. Data: The Foundation of Algorithm Learning - Data quality and diversity are crucial for algorithm performance, with sources categorized into real data, synthetic data, and web data. Real data is the most accurate but least abundant [3][74][76]. - The report emphasizes the importance of remote operation and motion capture technologies for collecting high-quality real data [3][79]. 3. Control Systems: The Foundation of Embodied Intelligence - The control system is described as the "brain" of humanoid robots, consisting of hardware (SoC chips, CPUs, GPUs, NPUs) and software components [3][3][3]. - The report notes that the industry lacks a unified consensus on the structure of the "brain" and "cerebellum" in humanoid robots, which are essential for executing complex algorithms and tasks [3][3][3]. 4. Investment Opportunities - The report identifies several key companies in the humanoid robot industry worth monitoring, including: - Controller segment: Tianzhun Technology, Zhiwei Intelligent, Desay SV [4][4]. - Motion control technology: Huichuan Technology, Xinjie Electric, Leisai Intelligent, Gokong Technology, Tosida [4][4]. - Chip manufacturers: Rockchip, Horizon Robotics [4][4]. - Data collection equipment: Lingyun Optical, Aofei Entertainment [4][4].

2024 年年度股东大会的 法律意见书 二〇二五年五月 广东华商律师事务所 关于 深圳市雷赛智能控制股份有限公司 广东华商律师事务所 关于深圳市雷赛智能控制股份有限公司 2024年年度股东大会的 法律意见书 本所律师根据有关法律法规的要求，按照律师行业公认的业务标准、道德规 范和勤勉尽责精神，对于出具本法律意见书有关的文件和以下事实进行了核查和 见证，现就本次股东大会涉及的相关法律事项出具法律意见如下： 一、本次股东大会的召集和召开程序 致：深圳市雷赛智能控制股份有限公司 广东华商律师事务所（以下简称"本所"）接受深圳市雷赛智能控制股份有 限公司（以下简称"公司"）的委托，指派本所律师（以下简称"本所律师"） 对公司2024年年度股东大会（以下简称"本次会议"）的相关事项进行见证。本 所律师依据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人 民共和国公司法》（以下简称"《公司法》"）、《上市公司股东会规则》（以 下简称"《股东会规则》"）等法律、法规和规范性法律文件以及《深圳市雷赛 智能控制股份有限公司章程》（以下简称"《公司章程》"）的规定，出具本法 律意见书。 本法律意见书仅对本次会议召集和 ...

证券代码：002979 证券简称：雷赛智能 公告编号：2025-029 深圳市雷赛智能控制股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无增加、变更、否决议案的情况； 2、本次股东大会不涉及变更前次股东大会决议； 3、本次股东大会采取现场投票与网络投票相结合的表决方式； 4、本次会议部分议案为特别决议事项，已由出席股东大会的股东（包括股 东代理人）所持表决权的 2/3 以上通过。 一、会议召开情况 1、会议召集人：公司第五届董事会。 2、会议召开时间： （1）现场会议时间：2025 年 5 月 15 日（星期四）下午 14:30 点开始； （2）网络投票时间：通过深圳证券交易所系统进行网络投票的时间为 2025 年 5 月 15 日（星期四）即上午 9:15 至 9:25、9:30 至 11:30、下午 13:00 至 15:00； 通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）进行网络 投票的时间为 2025 年 5 月 15 日（星期四）上 ...

关于 2022 年股票期权激励计划部分股票期权 注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 能"） 本次注销2022年股票期权激励计划部分股票期权合计134,903份，占公 司目前总股本的0.04%，涉及激励对象合计20人； 注销事宜已于2025年5月12日办理完成。 一、已履行的相关审批程序 证券代码：002979 证券简称：雷赛智能 公告编号：2025-028 深圳市雷赛智能控制股份有限公司 第九次会议，审议通过了《关于调整 2022 年股票期权激励计划业绩考核指标的 议案》，同意调整 2022 年限制性股票激励计划部分业绩考核指标，并修订《2022 年股票期权激励计划（草案）》及摘要、《2022 年股票期权激励计划实施考核管 理办法》相应条款。 十次会议审议通过了《关于调整 2022 年限制性股票激励计划回购价格、2022 年股票期权激励计划行权价格的公告》，经调整后，限制性股票回购价格由 7.66 元/股调整为 7.54 元/股，股票期权行权价格由 20.07 元/股调整为 19.95 元/ 股。 次会议审议通过了《关于 ...

证券代码：002979 证券简称：雷赛智能 公告编号：2025-028 深圳市雷赛智能控制股份有限公司 关于 2022 年股票期权激励计划部分股票期权 注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、深圳市雷赛智能控制股份有限公司（以下简称"公司"或"雷赛智 能"） 本次注销2022年股票期权激励计划部分股票期权合计134,903份，占公 司目前总股本的0.04%，涉及激励对象合计20人； 2、经中国证券登记结算有限责任公司深圳分公司确认，公司本次股票期权 注销事宜已于2025年5月12日办理完成。 一、已履行的相关审批程序 1、2022 年 8 月 25 日，公司第四届董事会第十七次会议审议通过了《关于 公司<2022 年股票期权激励计划（草案）>及摘要的议案》《关于公司<2022 年股 票期权激励计划实施考核管理办法>的议案》《关于提请股东大会授权董事会办 理公司 2022 年股票期权激励计划有关事宜的议案》。同日，公司第四届监事会 第十四次会议审议上述议案并对本期激励计划的激励对象名单进行核实，公司独 立董事就本期激励计划 ...

Group 1 - Public fund institutions remained active in research activities, with 146 institutions participating in A-share company research from May 5 to May 11, covering 156 stocks across 24 industries, totaling 1198 research instances [1][2] - The mechanical equipment sector stood out, with LeiSai Intelligent (002979) leading with 54 research instances, attracting nearly 30% of public institutions, while Honghua Digital Technology also received 33 instances [1][2] - The pharmaceutical and biological industry was another focus, with three stocks in the top ten, including Baiji Shenzhou, YiHe JiaYe (301367), and AoHua Endoscopy, receiving 49, 44, and 35 research instances respectively, indicating strong market interest in innovative drugs and medical devices [1][2] Group 2 - The electronic, pharmaceutical, and mechanical equipment sectors were the main areas of focus for public fund research, with electronic industry leading at 201 instances, followed by pharmaceutical at 194, and mechanical equipment at 143 [2] - A significant concentration of research activity was noted, with over 60% of public institutions conducting more than four research activities, and nine leading institutions exceeding 20 research instances [2][3] - Among the top ten active public institutions, Penghua Fund Management conducted 28 research instances, focusing on stocks like Naer Shares (002825), Oulutong (300870), and Honghua Digital Technology, which had notable weekly gains [3]

Core Viewpoint - Public fund institutions remain highly active in conducting research on A-share companies, with a total of 146 institutions participating in 1,198 research instances during the week of May 5 to May 11, 2025, covering 156 stocks across 24 primary industries [1]. Group 1: Top Stocks in Research - The top ten stocks with the highest research frequency include: - LeiHan Intelligent (54 times, +3.41%) - BeiGene (49 times, -6.76%) - YiHe JiaYe (44 times, +10.70%) - DeMingLi (37 times, -3.14%) - XiangXin Technology (36 times, +5.32%) - AoHua Endoscopy (35 times, +4.30%) - WenJian Medical (35 times, -1.47%) - HongHua Digital Science (33 times, +8.77%) - XingYe YinXi (31 times, -1.73%) - ZhouDaSheng (29 times, +0.77%) [2]. Group 2: Industry Focus - The mechanical equipment industry stands out with LeiHan Intelligent leading in research frequency, attracting nearly 30% of public institutions [2]. - The pharmaceutical and biotechnology sector is also a major focus, with BeiGene and YiHe JiaYe ranking second and third in research frequency, respectively [3]. - The electronic, pharmaceutical, and mechanical equipment sectors are the primary areas of interest for public fund research, with a total of 538 research instances, accounting for 44.91% of all public fund research activities [3].

Summary of Key Points from Conference Call Industry Overview - The conference call focuses on the development of dexterous hands in the robotics industry, particularly in the context of human-like manipulation and control technologies [1][2][4][5][6][8][30]. Core Insights and Arguments - **Dexterous Hand Structure**: Dexterous hands are designed with up to 21 degrees of freedom, closely mimicking human hand anatomy, which is essential for fine manipulation [1][3]. - **Key Components**: The main components of dexterous hands include drive modules, transmission modules, and sensors. Various technologies are being explored to optimize performance, including hollow cup motors and brushless motors [1][6][14]. - **Tesla's Innovations**: Tesla has developed a dexterous hand with 22 total degrees of freedom and approximately 17 active degrees, utilizing a tendon-driven system and various sensors to enhance intelligence [1][7]. - **Domestic Manufacturers**: Companies like Lingqiao Technology, Leisai Intelligent, and Zhiyuan are actively developing and releasing products with advanced features such as tactile sensors and 3D force sensors [1][9][10][12][32]. - **Market Trends**: The domestic market is seeing a shift towards domestic alternatives in robotics, with companies establishing deep collaborations with downstream clients for mass production [4][13]. Additional Important Content - **Technological Diversity**: The industry is characterized by a variety of technological approaches, including tendon-driven, linkage-driven, and gear-driven systems, each with its own advantages and challenges [20][21][22]. - **Sensor Integration**: The rapid integration of electronic skin technology and tactile sensors is becoming standard in dexterous hands, significantly impacting performance and cost [30][31]. - **Cost Projections**: The cost of dexterous hands is expected to account for about 10% of the total value of humanoid robots, aligning with industry expectations for sensor costs [31]. - **Future Market Potential**: The market for dexterous hands is projected to grow significantly, with potential revenues reaching hundreds of billions as production scales up [19][26]. Competitive Landscape - **Domestic vs. International Players**: Domestic companies are making strides in the robotics field, with the potential to replace international competitors despite their earlier market entry [4][13]. - **Key Players**: Companies like Leisai Intelligent and Zhiyuan are highlighted as significant players due to their comprehensive capabilities in hardware and software integration [36]. Recommendations - **Focus on Key Companies**: It is recommended to monitor the developments of companies like Leisai Intelligent, which not only manufacture hardware but also provide essential algorithms and motion control solutions, addressing industry challenges effectively [36].

Group 1 - The core viewpoint of the news is that Jianshun Investment has conducted research on a listed company, specifically Leisai Intelligent, which is expected to achieve significant revenue and profit growth in the coming years [1] - Leisai Intelligent anticipates a revenue of 1.584 billion yuan in 2024, representing a year-on-year increase of 11.93%, and a net profit of 200.5 million yuan, reflecting a year-on-year growth of 44.67% [1] - The company has adopted a channel-focused strategy, complementing it with direct sales, and has successfully introduced over 100 new channel partners, totaling more than 200 partners and establishing over 30 offices [1] Group 2 - Leisai Intelligent's strategic focus is on the "smart manufacturing" main channel while also developing the "mobile robot" auxiliary channel, indicating a clear growth strategy [1] - The company aims for a revenue growth of 20%-30% and a net profit increase of 30%-50% by 2025, highlighting its ambitious growth targets [1] - The business is concentrated on two core markets: general automation and humanoid robots, which present significant future growth potential [1]

Group 1: Company Performance - In 2024, the company achieved a revenue of 1.584 billion CNY, a year-on-year increase of 11.93% [4] - The net profit attributable to shareholders was 200.5 million CNY, up 44.67% year-on-year, while the net profit excluding non-recurring items was 196.1 million CNY, an increase of 57.61% [4] - The overall market size of the OEM automation industry exceeds 100 billion CNY, with the overall automation market in China nearing 300 billion CNY in 2024 [6][7] Group 2: Market Challenges and Strategies - The automation industry is facing a 5% year-on-year decline in market size due to insufficient effective demand and significant downturns in the photovoltaic and lithium battery sectors [4] - The company plans to achieve a revenue growth of 20%-30% and a net profit growth of 30%-50% by 2025 [6] - The company is focusing on enhancing its marketing strategy by introducing over 200 new channel partners and establishing more than 30 offices in major cities [4][6] Group 3: Industry Trends and Opportunities - The humanoid robot market is projected to reach approximately 2.76 billion CNY in 2024, growing to 10.471 billion CNY by 2026, and potentially reaching 300 billion CNY by 2035 [6][9] - The global market for dexterous hands in humanoid robots is expected to reach 32.06 billion CNY by 2030, with a compound annual growth rate of 81.2% [9] - The company is leveraging government policies aimed at fostering "new quality productivity" to drive growth in the automation sector [6] Group 4: Product Development and Innovation - The company is focusing on core products such as servo systems, stepper systems, and control technology, providing comprehensive motion control solutions [5] - The establishment of subsidiaries like Shanghai Leisai Robot Technology Co., Ltd. and Shenzhen Agile Drive Control Technology Co., Ltd. aims to enhance product offerings in high-density motors and dexterous hands [7][9] - The company is actively developing a "brain" for robotic motion control systems, with several products already in the R&D phase [8]